Production (Stage)
CARGO Therapeutics, Inc.
CRGX
$4.43
$0.061.37%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -216.19M | -167.50M | -154.14M | -147.71M | -121.21M |
| Total Depreciation and Amortization | 6.44M | 7.07M | 6.81M | 6.08M | 4.86M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 27.16M | 14.91M | 11.67M | 16.55M | 14.79M |
| Change in Net Operating Assets | 35.30M | 5.77M | 1.83M | 7.65M | 4.32M |
| Cash from Operations | -147.29M | -139.74M | -133.84M | -117.43M | -97.25M |
| Capital Expenditure | -3.54M | -4.45M | -6.43M | -8.98M | -9.01M |
| Sale of Property, Plant, and Equipment | 223.00K | 223.00K | 223.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 27.24M | -300.86M | -330.11M | -288.07M | -293.32M |
| Cash from Investing | 23.92M | -305.08M | -336.32M | -297.04M | -302.33M |
| Total Debt Issued | -- | -- | 0.00 | 0.00 | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 104.10M | 104.09M | 400.41M | 400.01M | 296.67M |
| Repurchase of Common Stock | 0.00 | -25.00K | -25.00K | -25.00K | -25.00K |
| Issuance of Preferred Stock | -- | -- | 86.01M | 131.84M | 131.84M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -488.00K | -593.00K | -4.84M | -5.58M | -5.58M |
| Cash from Financing | 103.61M | 103.47M | 481.56M | 526.25M | 422.90M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -19.76M | -341.35M | 11.40M | 111.78M | 23.33M |